UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended March 31, 2003


Commission File Number 1-8635

                          AMERICAN MEDICAL ALERT CORP.
        (Exact Name of Small Business Issuer as Specified in its Charter)

New York                                                11-2571221
(State or other jurisdiction of                         (I.R.S. Employer
incorporation or organization)                          Identification Number)

                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
                (Issuer's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X     No
                                      ---      ---

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  7,426,739 shares of $.01 par
value common stock as of May 8, 2003.


<PAGE>

                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES


                                      INDEX


                                                                            PAGE

Part I.   Financial Information.

             Report of Independent Accountants                                 1

             Condensed Consolidated Balance Sheets for March 31, 2003
             and December 31, 2002                                             2

             Condensed Consolidated Statements of Income for the
             Three Months Ended March 31, 2003 and 2002                        4

             Condensed Consolidated Statements of Cash Flows for the
             Three Months Ended March 31, 2003 and 2002                        5

             Notes to Condensed Consolidated Financial Statements              7

             Management's Discussion and Analysis of
             Financial Condition and Results of Operations.                   12


Part II. Other Information                                                    20


<PAGE>
Report of Independent Accountants

Board of Directors and Shareholders
American Medical Alert Corp. and Subsidiaries
Oceanside, New York

We have reviewed the condensed  consolidated  balance sheet of American  Medical
Alert Corp.  and  Subsidiaries  as of March 31,  2003 and the related  condensed
consolidated  statements  of income and cash flows for the  three-month  periods
ended March 31, 2003 and 2002. These financial statements are the responsibility
of the company's management.

We  conducted  our  reviews in  accordance  with  standards  established  by the
American  Institute  of  Certified  Public  Accountants.  A  review  of  interim
financial information consists principally of applying analytical procedures and
making inquiries of persons responsible for financial and accounting matters. It
is  substantially  less in scope  than an audit  conducted  in  accordance  with
generally accepted auditing standards,  the objective of which is the expression
of an opinion regarding the financial statements taken as a whole.  Accordingly,
we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to the condensed consolidated financial statements referred to above for
them to be in conformity with accounting  principles  generally  accepted in the
United States of America.

We have  previously  audited,  in accordance with auditing  standards  generally
accepted in the United  States of America,  the  consolidated  balance  sheet of
American  Medical Alert Corp. and  subsidiaries as of December 31, 2002, and the
related consolidated  statements of income,  shareholders' equity and cash flows
for the year then ended (not  presented  herein);  and in our report dated March
20, 2003, we expressed an unqualified  opinion on those  consolidated  financial
statements.  In our  opinion,  the  information  set  forth in the  accompanying
condensed  consolidated  balance sheet as of December 31, 2002 is fairly stated,
in all material  respects,  in relation to the  consolidated  balance sheet from
which it has been derived.

/s/ Margolin, Winer & Evens LLP

Margolin, Winer & Evens LLP

May 8, 2003


                                      -1-
<PAGE>

                         PART I - FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS.

                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>

                                     ASSETS

                                                                          March 31, 2003
                                                                            (Unaudited)    Dec. 31, 2002
                                                                         ---------------  --------------
<S>                                                                      <C>              <C>
CURRENT ASSETS
     Cash                                                                $  1,214,415     $    863,417
     Marketable securities                                                  1,557,925        2,057,925
     Accounts receivable
     (net of allowance for doubtful accounts of $555,000 and $540,000)      2,993,344        2,984,857
     Notes and other receivables                                               79,601           75,792
     Inventory                                                                381,599          373,423
     Prepaid and refundable taxes                                             221,172          271,572
     Prepaid expenses and other current assets                                223,060          239,168
     Deferred income taxes                                                    300,000          292,000
                                                                         ------------     ------------
     Total Current Assets                                                   6,971,116        7,158,154
                                                                         ------------     ------------
FIXED ASSETS
      (Net of accumulated depreciation and amortization)                     7,036,265        7,221,088
                                                                         ------------     ------------
OTHER ASSETS
       Long-term portion of notes receivable                                  136,154          143,391
       Intangible assets
         (net of accumulated amortization of $660,620 and $599,304)         1,076,594        1,123,870
       Goodwill (net of accumulated amortization of $58,868)                  990,557          961,731
       Other assets                                                           214,526          218,413
       Deferred income taxes                                                  186,000          154,000
                                                                         ------------     ------------
                                                                            2,603,831        2,601,405
                                                                         ------------     ------------

TOTAL ASSETS                                                             $ 16,611,212     $ 16,980,647
                                                                         ============     ============

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
     Current portion of notes payable                                    $    297,841     $    293,529
     Accounts payable                                                         485,166          681,927
     Accrued expenses                                                         623,288          816,569
     Current portion of capital lease obligations                             130,187          158,617
     Current portion of put warrant obligation                                288,000          251,000
     Deferred revenue                                                         100,751          150,294
                                                                         ------------     ------------
     Total Current Liabilities                                              1,925,233        2,351,936



                                      -2-
<PAGE>



DEFERRED INCOME TAX LIABILITY                                                 637,000          597,000
LONG-TERM PORTION OF NOTES PAYABLE                                          1,012,266        1,079,506
LONG-TERM PORTION OF CAPITAL LEASE OBLIGATIONS                                172,513          156,448
LONG-TERM PORTION OF PUT WARRANT OBLIGATION                                   201,000          181,000
ACCRUED RENTAL OBLIGATION AND OTHER                                            58,500           55,500
                                                                         ------------     ------------
     TOTAL LIABILITIES                                                      4,006,512        4,421,390
                                                                         ------------     ------------

COMMITMENTS AND CONTINGENT LIABILITIES
SHAREHOLDERS' EQUITY
     Preferred stock, $.01 par value - authorized, 1,000,000
     shares; none issued and  outstanding
     Common  stock, $.01 par  value -  authorized
     20,000,000 shares; issued 7,470,649 shares
     in 2003 and 2002, respectively                                            74,706           74,706
     Additional paid-in capital                                             8,999,172        8,999,172
     Retained earnings                                                      3,636,854        3,591,411
                                                                         ------------     ------------
                                                                           12,710,732       12,665,289
     Less treasury stock, at cost (43,910 shares)                            (106,032)        (106,032)
                                                                         ------------     ------------
     Total Shareholders' Equity                                            12,604,700       12,559,257
                                                                         ------------     ------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY                               $ 16,611,212     $ 16,980,647
                                                                         ============     ============
</TABLE>


                                      -3-
<PAGE>

                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                  (Unaudited)

<TABLE>
<CAPTION>

                                                                           Three Months Ended March 31,
                                                                              2003            2002
                                                                         ---------------  --------------
<S>                                                                      <C>              <C>
Revenues:
     Services                                                            $  3,779,829     $  3,521,687
     Product sales                                                            121,658           87,576
                                                                         ------------     ------------
                                                                            3,901,487        3,609,263
Costs and Expenses (Income):
     Costs related to services                                              1,812,364        1,611,893
     Costs of products sold                                                    68,745           48,799
     Selling, general and administrative expenses                           1,990,137        1,773,254
     Interest expense                                                          21,302           35,837
     Other income                                                             (94,504)         (13,291)
                                                                         ------------     ------------

Income before Provision for Income Taxes                                      103,443          152,771

Provision for Income Taxes                                                     58,000           73,000
                                                                         ------------     ------------

NET INCOME                                                               $     45,443     $     79,771
                                                                         ============     ============
Net income per share:
     Basic                                                               $        .01     $        .01
                                                                         ------------     ------------
     Diluted                                                             $        .01     $        .01
                                                                         ------------     ------------

Weighted average number of common shares outstanding (Note 3)
     Basic                                                                  7,426,739        6,475,175
                                                                         ============     ============

     Diluted                                                                7,525,330        7,004,285
                                                                         ============     ============
</TABLE>

See accompanying notes to condensed financial statements.



                                      -4-
<PAGE>


                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                            Three Months Ended March 31,
                                                                2003          2002
                                                                ----          ----
<S>                                                         <C>          <C>
Cash Flows From Operating Activities:

     Net income                                             $  45,443      $  79,771

     Adjustments  to  reconcile  net income to net cash
       provided  by  operating activities:

     Depreciation and amortization                            531,237        479,042
     Valuation of put warrants                                 57,000         25,000
     Decrease (increase) in:
       Accounts receivables                                    (8,487)       (32,807)
       Inventory                                               (8,176)         1,621
        Prepaid and refundable taxes                           50,400        (10,234)
       Prepaid expenses and other current assets               16,108        (68,597)
        Other assets                                               --       (109,541)
     (Decrease) in:
       Accounts payable, accrued expenses and other          (387,042)      (156,338)
        Deferred revenue                                      (49,543)       (38,891)
                                                            ---------      ---------

Net Cash Provided by Operating Activities                     246,940        169,026
                                                            ---------      ---------

Cash Flows From Investing Activities:
     Expenditures for fixed assets                           (236,211)       (61,284)
     Investments in marketable securities                     500,000             --
     Repayment of notes receivable                              3,428         10,413
     Increase in goodwill                                     (28,826)            --
     Payment for account acquisitions and
      licensing agreement                                     (14,040)      (245,663)
                                                            ---------      ---------

Net Cash Provided by (Used In) Investing Activities           224,351       (296,534)
                                                            ---------      ---------

Cash Flows From Financing Activities:
     Principal payments under capital lease obligation        (57,365)       (51,835)
     Proceeds from notes payable                               16,049             --
     Repayment of notes payable                               (78,977)       (97,144)
     Proceeds upon exercise of stock options                       --         55,705
                                                            ---------      ---------

Net Cash Used in Financing Activities                        (120,293)       (93,274)
                                                            ---------      ---------

See accompanying notes to condensed financial statements



                                      -5-
<PAGE>


                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
                                   (Unaudited)

                                                            Three Months Ended March 31,
                                                                2003          2002
                                                                ----          ----
         Net Increase (Decrease)  in Cash                   $  350,998     $ (220,782)

         Cash, Beginning of Period                             863,417        818,696
                                                            ----------     ----------

         Cash, End of Period                                $1,214,415     $  597,914
                                                            ==========     ==========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

CASH PAID DURING THE PERIOD FOR INTEREST                    $   21,302     $   34,938
                                                            ==========     ==========

CASH PAID DURING THE PERIOD FOR INCOME TAXES                $    6,735     $   34,192
                                                            ==========     ==========

SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING
 AND FINANCING ACTIVITY:

  Fixed assets recorded under capital lease obligations     $   45,000     $       --
</TABLE>

See accompanying notes to condensed financial statements.



                                      -6-
<PAGE>
                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES


              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)


1.   General:

         These  financial  statements  should  be read in  conjunction  with the
financial  statements  and notes  thereto for the year ended  December  31, 2002
included in the Company's Annual Report on Form 10-KSB.

2.   Results of Operations:

         In the opinion of  management,  the  accompanying  unaudited  condensed
financial  statements  contain  all  adjustments   (consisting  only  of  normal
recurring  accruals)  necessary to present  fairly the financial  position as of
March 31, 2003 and the results of operations and cash flows for the three months
ended March 31, 2003 and 2002.

         The accounting  policies used in preparing these  financial  statements
are the same as those  described in the December 31, 2002 financial  statements,
except as described in Note 3.

         The results of operations for the three months ended March 31, 2003 are
not  necessarily  indicative of the results to be expected for any other interim
period or for the full year.

3.       New Pronouncements:

         In April 2002,  SFAS No. 145,  "Rescission of FASB Statements No. 4, 44
and 64,  Amendment of FASB  Statement  No. 13, and  Technical  Corrections"  was
issued. This statement (i) eliminates  extraordinary  accounting treatment for a
gain  or  loss  reported  on  the   extinguishment   of  debt,  (ii)  eliminates
inconsistencies in the accounting  required for sale-leaseback  transactions and
certain lease  modifications  with similar  economic  effects,  and (iii) amends
other  existing  authoritative  pronouncements  to make  technical  corrections,
clarify meanings, or describe their applicability under changed conditions.  The
Company  adopted SFAS No. 145  effective  January 1, 2003.  The adoption of this
statement  has  not  had a  material  impact  on  the  consolidated  results  of
operations or financial position.

         In June 2002, SFAS No. 146,  "Accounting for Costs Associated with Exit
or Disposal  Activities" was issued.  This statement nullifies existing guidance
related  to the  accounting  and  reporting  for costs  associated  with exit or
disposal  activities and requires that the fair value of a liability  associated
with an exit or disposal  activity be recognized when the liability is incurred.
Under  previous  guidance,  certain exit costs were permitted to be accrued upon
management's  commitment  to an exit plan,  which is generally  before an actual
liability has been incurred. The provisions of this statement are required to be
adopted for all exit or disposal  activities  initiated after December 31, 2002.
This statement will not impact any liabilities  recorded prior to


                                      -7-
<PAGE>

adoption.  The  Company  adopted  SFAS No. 146  effective  January 1, 2003.  The
adoption of this  statement  has not had a material  impact on the  consolidated
results of operations or financial position.

         In December 2002, the FASB issued SFAS No. 148,  "Accounting  for Stock
Based  Compensation - Transition and Disclosure,  an Amendment of FASB Statement
123". SFAS No. 148 provides new transition  alternatives for companies  adopting
the fair value method of accounting for stock-based  compensation  prescribed by
SFAS No.  123.  SFAS No. 148 also  requires  that  disclosures  of the pro forma
effect of using the fair value method of  accounting  for  stock-based  employee
compensation be displayed more prominently and in tabular format.  Additionally,
SFAS No. 148 requires  disclosures of the pro forma effect in interim  financial
statements.  The  Company  has chosen to  continue  to account  for  stock-based
compensation  using the intrinsic value method  prescribed in APB Opinion No. 25
and  related   interpretations.   The  Company  adopted  the  annual  disclosure
provisions of SFAS No. 148 in its financial  report for the year ended  December
31, 2002 and adopted the interim disclosure provisions for its financial reports
for the quarter ended March 31, 2003.

4.   Accounting for Stock-Based Compensation:

         The Company has three  stock-based  employee  compensation  plans.  The
Company   accounts  for  those  plans  under  the  recognition  and  measurement
principles of APB Opinion No. 25,  "Accounting  for Stock Issued to  Employees",
and  related  interpretations.  No  stock-based  employee  compensation  cost is
reflected  in net  income,  as all  options  granted  under  those  plans had an
exercise price equal to the market value of the  underlying  common stock on the
date of grant.  The following table  illustrates the effect on net income (loss)
and  earnings  (loss)  per  share if the  Company  had  applied  the fair  value
recognition   provisions   of  SFAS  No.  123,   "Accounting   for   Stock-Based
Compensation," to stock-based compensation.

                                          Quarter Ended March 31,
                                         2003                 2002
                                         ----                 ----
Net income, as reported             $    45,443           $    79,771
Deduct: Total stock-based
  employee compensation
  expense determined under
  fair value based method              (142,516)             (312,518)
                                    -----------           -----------
Pro forma net loss                  $   (97,073)          $  (232,747)

Earnings (loss) per share:
  Basic - as reported               $      0.01           $      0.01
  Basic - pro forma                 $     (0.01)          $     (0.04)
  Diluted - as reported             $      0.01           $      0.01
  Diluted - pro forma               $     (0.01)          $     (0.04)



                                      -8-
<PAGE>

The  weighted  average  grant  date fair  value of  options  granted  during the
quarters ended March 31, 2003 and 2002 was $69,283 and $434,868, respectively.

The fair value of options at date of grant was estimated using the Black-Scholes
model with the following weighted average assumptions:

                                     2003           2002
                                     ----           ----

Expected life (years)                2               2
Risk free interest rate              1.70%           3.21%
Expected volatility                 38.80%          36.72%
Expected dividend yield                --              --

5.   Earnings Per Share:

         Earnings  per share data for the three  months ended March 31, 2003 and
2002 is presented in conformity with SFAS No. 128, "Earnings Per Share".

         The  following  table  is  a  reconciliation   of  the  numerators  and
denominators in computing earnings per share:

<TABLE>
<CAPTION>

                                                          Income                  Shares              Per-Share
                    March 31, 2003                      (Numerator)            (Denominator)           Amounts
                    --------------                    -------------            -------------        ------------
<S>                                                    <C>                     <C>                     <C>
         Basic EPS -
             Income available to
                  common stockholders                  $  45,443               7,426,739               $   .01
                                                                                                       =======

         Effect of dilutive securities -
             Options and warrants                             --                  98,591
                                                       ---------               ---------
         Diluted EPS -
             Income available to common
                  stockholders and
                  assumed conversions                  $  45,443               7,525,330               $   .01
                                                       =========               =========               =======

                    March 31, 2002
                    --------------

         Basic EPS -
             Income available to
                  common stockholders                  $  79,771               6,475,175               $   .01
                                                                                                       =======
         Effect of dilutive securities -
             Options and warrants                             --                 529,110
                                                       ---------               ---------
         Diluted EPS -
             Income available to common
                  stockholders and
                  assumed conversions                  $  79,771               7,004,285               $   .01
                                                       =========               =========               =======
</TABLE>

                                      -9-
<PAGE>


6.   Major Customers:

Since  1983,  the Company  has  provided  Personal  Emergency  Response  Systems
("PERS") services to the City of New York's Human Resources  Administration Home
Care Service Program ("HCSP").  During the three months ended March 31, 2003 and
2002,  the  Company's  revenues  from  this  contract  represented  20% and 25%,
respectively, of its total revenue.

Since  January 1999,  the Company has provided  services to the City of New York
under  extensions  and  contracts  issued  periodically.  The  current  contract
reflects  terms and  conditions  present in the original  contract.  In November
2002,  in response to a Request For Proposal  ("RFP")  issued by HCSP,  AMAC and
several other companies  submitted  proposals to provide PERS services on behalf
of the City of New York for the period July 1, 2003 through June 30, 2006.

During any contract  renewal  process,  there can be no assurance  that the same
level of  revenues  will be  sustained  due to a variety of  factors,  including
pricing,  number of  subscribers  to be  serviced,  and the  amount of time that
passes before the renewal agreement is acted upon by HCSP. While the Company has
reduced  its  dependence  on revenue  from  HCSP,  a  significant  amount of the
Company's  revenue  could be  lost,  albeit  over a  protracted  period,  if the
contract with HCSP is not maintained or is maintained at a  significantly  lower
level of revenue. This could have a material adverse effect on operating results
and cash flows.  In addition,  it is possible that  significant  adjustments  to
leased medical devices  associated with the contract would occur. The extent and
significance  of the  adjustments  will be  dependant  upon  the  length  of the
transition  period to the new provider subject to management's  ability to place
these devices with other providers.

As of March 31, 2003 and December 2002,  accounts  receivable  from the contract
represented 39% and 41%, respectively, of accounts receivable and leased medical
devices in service  under the contract  represented  approximately  19% and 20%,
respectively, of leased medical devices.



                                      -10-
<PAGE>

7.      Segment  Reporting:

The Company has two reportable  segments,  Personal  Emergency  Response Systems
("PERS") and Telephone After-Hours Answering Services ("TAS"), which is provided
through the Company's HCI subsidiary, which was acquired on November 21, 2000.

The table  below  provides  a  reconciliation  of segment  information  to total
consolidated information for the three months ended March 31, 2003 and 2002:

<TABLE>
<CAPTION>

                                      2003
                                      ----

                                                                      PERS             TAS             Other        Consolidated
                                                                      ----             ---             -----        ------------
<S>                                                               <C>             <C>             <C>              <C>
         Revenue                                                  $ 3,107,497     $   724,805     $    69,185      $ 3,901,487
         Income (loss) before provision for
         income taxes                                                  10,100          96,090          (2,747)         103,443
         Total assets                                              13,938,794       2,347,521         324,897       16,611,212


                                      2002
                                      ----
                                                                      PERS             TAS             Other        Consolidated
                                                                      ----             ---             -----        ------------

         Revenue                                                  $ 2,972,254     $   605,798     $    31,211      $ 3,609,263
         Income (loss) before provision for
         income taxes                                                  74,896          78,319            (444)         152,771
         Total assets                                              11,900,978       2,157,003         189,630       14,247,611
</TABLE>

8.   Contingencies:

The Company is aware of various  threatened or pending litigation claims against
the Company  relating to its products and arising in the ordinary  course of its
business.  The Company has given its insurance carrier notice of such claims and
it believes there is sufficient  insurance coverage to cover any such claims. In
any event, the Company believes the disposition of these matters will not have a
material adverse effect on the financial condition of the Company.

On March 2, 2001  American  Medical  Alert  Corp.  was served with a Summons and
Complaint by a former employee seeking to recover damages for discrimination and
harassment in connection  with her  employment  and the  associated  termination
thereof.  The action is  pending  in the  Supreme  Court of Queens  County.  The
plaintiff  seeks to recover the sum of  $750,000  for  compensatory  damages and
$750,000  for  punitive  damages.  At this stage of the  proceedings,  it is not
possible to predict the outcome of this litigation; however, management believes
that the


                                      -11-
<PAGE>

Company has  meritorious  defenses to the  complaint.  The Company is  currently
involved in settlement  negotiations with respect to this matter. At the present
time the insurance company has declined coverage.

9.   Subsequent Events:

On January 14, 2002, the Company  entered into an operating  lease agreement for
space in Long  Island  City,  New York in an effort to  consolidate  its HCI and
Oceanside  ERC and  Customer  Service  facilities.  The  Company  believes  that
centralization  of the ERC,  Customer Service and H-Link OnCall operations would
provide  additional  efficiencies  and  facilitate  the projected  growth of the
H-Link and Disease Management Monitoring  operations.  The lease term is fifteen
(15) years which commenced in April 2003 when the property was first occupied by
the Company. The lease calls for minimum annual rentals of $269,500,  subject to
a 3% annual  increase plus  reimbursement  for real estate taxes. As a result of
this  transaction,  the Company and the building  are  eligible for  significant
Relocation and Employment  Assistance Program (REAP) and other tax incentive and
cost  savings  benefits  from  the  City  of New  York.  The  Company  plans  to
consolidate  certain  facilities  and intends to offer for sale the  condominium
currently occupied by HCI Acquisition Corp.

ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
           RESULTS OF  OPERATIONS.
           ---------------------------------------------------------------

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report dated December 31, 2002.

Statements   contained  in  this   Quarterly   Report  on  Form  10-QSB  include
"forward-looking statements" within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act,  including,  in particular  and without
limitation,   statements  contained  herein  under  the  heading   "Management's
Discussion  and  Analysis of  Financial  Condition  and Results of  Operations."
Forward-looking  statements  involve known and unknown risks,  uncertainties and
other factors which could cause the Company's  actual  results,  performance and
achievements,  whether expressed or implied by such forward-looking  statements,
not to occur or be realized.  These include uncertainties relating to government
regulation,  technological  changes,  our expansion plans and product  liability
risks. Such  forward-looking  statements  generally are based upon the Company's
best estimates of future results, performance or achievement, based upon current
conditions and the most recent results of operations. Forward-looking statements
may be  identified  by the use of  forward-looking  terminology  such as  "may,"
"will," "expect,"  "believe,"  "estimate,"  "anticipate,"  "continue" or similar
terms, variations of those terms or the negative of those terms.

You should carefully  consider such risks,  uncertainties and other information,
disclosures  and discussions  which contain  cautionary  statements  identifying
important  factors that could cause


                                      -12-
<PAGE>

actual results to differ  materially from those provided in the  forward-looking
statements.  Readers  should  carefully  review the risk  factors  and any other
cautionary  statements  contained in the Company's  Annual Report on Form 10-KSB
and other public  filings.  The Company  undertakes  no  obligation  to publicly
update or revise  any  forward-looking  statements,  whether  as a result of new
information, future events or otherwise.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

In April 2002, the Company raised $2,521,939,  after expenses of $208,061,  in a
private  equity  placement of the Company's  common stock and warrants.  Several
investors purchased an aggregate of 910,000 shares of the Company's common stock
and  warrants to purchase  227,500  shares of the  Company's  common stock at an
exercise price of $3.80 per share until April 2007. As part of this transaction,
the  Company  registered  for  resale  the  common  stock and the  common  stock
underlying  the  warrants  sold in the private  placement.  The Company has been
utilizing a majority of the proceeds from this  offering to further  execute its
business  expansion  and  diversification   strategy  into  the  remote  patient
monitoring and medical contact center industries,  including its initiative with
HHN.

In connection  with the private  placement,  the Company issued to the placement
agent two  warrants to purchase  91,000 and 22,750  shares of common stock at an
exercise  price of $3.83 per share and  $4.17  per  share,  respectively.  These
warrants have the same terms as the warrants issued with the common stock.

In May  2002,  the  Company  completed  negotiations  with a bank,  for which it
received  a  credit  facility  of  $3,000,000,  which  includes  a term  loan of
$1,500,000  and a  revolving  credit line that  permits  maximum  borrowings  of
$1,500,000  (based on eligible  receivables,  as defined).  Borrowings under the
term loan will bear interest at either (a) LIBOR plus 3.5% or (b) the prime rate
or the federal funds  effective rate plus .5%,  whichever is greater,  plus 1.0%
and the  revolving  credit line will bear interest at either (a) LIBOR plus 3.0%
or (b) the prime rate or the federal funds effective rate plus .5%, whichever is
greater, plus .5%. The Company has the option to choose between the two interest
rate options  under the term loan and  revolving  credit line.  The term loan is
payable in equal monthly principal payments of $25,000 over five years while the
revolving credit line is available for three years.  The outstanding  balance on
the  term  loan at  March  31,  2003  was  $1,250,000.  There  were  no  amounts
outstanding on the revolving credit line at March 31, 2003.

At March 31, 2003, the Company was in compliance  with its loan covenants  under
the agreement dated May 20, 2002.



                                      -13-
<PAGE>

The  following  table is a summary of  contractual  obligations  as of March 31,
2003:

<TABLE>
<CAPTION>

                                                                Payments Due by Period
--------------------------------------------------------------------------------------------------------------
                                                     Less than 1
Contractual Obligations            Total             year            1-3 years       4-5 years      After 5 years
--------------------------------------------------------------------------------------------------------------
<S>                              <C>               <C>             <C>              <C>            <C>
Revolving Credit Line            $     -0-

Debt                             $1,310,107        $   297,841     $  937,266       $  75,000

Capital Leases                   $  302,700        $   130,187     $  172,513

Operating Leases                 $6,125,994        $   550,530     $1,583,416       $ 722,877      $ 3,269,171

Total Contractual
 Cash Obligations                $7,738,801        $   978,558     $2,693,195       $ 797,877      $ 3,269,171
--------------------------------------------------------------------------------------------------------------
</TABLE>

The Company's  working  capital on March 31, 2003 was  $5,045,883 as compared to
$4,806,218 on December 31, 2002. The Company  believes that its present cash and
working  capital  position  combined with its borrowing  availability  under its
credit facility and future  anticipated cash flow generated from operations will
be sufficient  to meet its cash and working  capital needs for at least the next
12  months.   During  2003,  the  Company   anticipates  it  will  make  capital
expenditures of approximately $1,000,000 - $1,250,000 for the enhancement of its
management information systems,  leasehold improvements in its Long Island City,
New York  premises,  and the  production  and  purchase  of the PERS  Buddy  and
additional PERS.

Other Factors:

On January 14, 2002, the Company  entered into an operating  lease agreement for
space in Long  Island  City,  New York in an effort to  consolidate  its HCI and
Oceanside  ERC and  Customer  Service  facilities.  The  Company  believes  that
centralization  of the ERC,  Customer Service and H-Link OnCall operations would
provide  additional  efficiencies  and  facilitate  the projected  growth of the
H-Link and Disease Management Monitoring  operations.  The lease term is fifteen
(15) years which commenced in April 2003 when the property was first occupied by
the Company. The lease calls for minimum annual rentals of $269,500,  subject to
a 3% annual  increase plus  reimbursement  for real estate taxes. As a result of
this  transaction,  the Company and the building  are  eligible for  significant
Relocation and Employment  Assistance Program (REAP) and other tax incentive and
cost  savings  benefits  from  the  City  of New  York.  The  Company  plans  to
consolidate  certain  facilities  and intends to offer for sale the  condominium
currently occupied by HCI Acquisition Corp.



                                      -14-
<PAGE>

On  November  1,  2001,  the  Company  entered  into  a  Cooperative  Licensing,
Development,  Services and Marketing  Agreement  with HHN (the "HHN  Agreement")
pursuant to which the Company is  developing,  with the assistance of HHN, a new
integrated  appliance  combining the features of the Company's PERS product with
HHN's  technology.  Pursuant  to the  HHN  Agreement,  the  Company  will be the
exclusive  manufacturer  and distributor  (based on achievement of certain sales
milestones),  in the United States, of an enhanced PERS system that combines the
Company's  traditional  safety  monitoring  features with HHN's  internet  based
disease  management  monitoring  technology.  The HHN  Agreement  has a  minimum
five-year term, and also provides for the payment by the Company of certain fees
based on the service revenue derived from the enhanced PERS product. The Company
anticipates the costs  associated  with the licensing,  research and development
and marketing with respect to the HHN Agreement to approximate  $2,000,000.  The
cost of the licensing  component will aggregate  $1,000,000,  the full amount of
which will be recorded  when certain  milestones  under the agreement are met by
the Company, at which time the cost will be amortized over the remaining portion
of the initial five year term of the  agreement.  The Company  anticipates  that
amortization will commence during the second quarter of 2003. As of May 8, 2003,
$508,610 has been paid towards the  licensing  component.  Related  professional
fees of approximately $115,000 have been capitalized.

Since  1983,  the Company  has  provided  Personal  Emergency  Response  Systems
("PERS") services to the City of New York's Human Resources  Administration Home
Care Service Program ("HCSP").  During the three months ended March 31, 2003 and
2002,  the  Company's  revenues  from  this  contract  represented  20% and 25%,
respectively, of its total revenue.

Since  January 1999,  the Company has provided  services to the City of New York
under  extensions  and  contracts  issued  periodically.  The  current  contract
reflects  terms and  conditions  present in the original  contract.  In November
2002,  in response to a Request For Proposal  ("RFP")  issued by HCSP,  AMAC and
several other companies  submitted  proposals to provide PERS services on behalf
of the City of New York for the period July 1, 2003 through June 30, 2006.

During any contract  renewal  process,  there can be no assurance  that the same
level of  revenues  will be  sustained  due to a variety of  factors,  including
pricing,  number of  subscribers  to be  serviced,  and the  amount of time that
passes before the renewal agreement is acted upon by HCSP. While the Company has
reduced  its  dependence  on revenue  from  HCSP,  a  significant  amount of the
Company's  revenue  could be  lost,  albeit  over a  protracted  period,  if the
contract with HCSP is not maintained or is maintained at a  significantly  lower
level of revenue. This could have a material adverse effect on operating results
and cash flows.  In addition,  it is possible that  significant  adjustments  to
leased medical devices  associated with the contract would occur. The extent and
significance  of the  adjustments  will be  dependant  upon  the  length  of the
transition  period to the new provider subject to management's  ability to place
these devices with other providers.



                                      -15-
<PAGE>

The  Company's  management  has  developed  and  implemented  a business plan to
minimize its  reliance on HCSP.  The  Company's  business  plan,  which has been
implemented  over the last 2 years, is focused on the building of the subscriber
base outside the New York City contract, through consumers, healthcare agencies,
health   maintenance   organizations,   durable  medical  equipment   providers,
retirement communities,  hospitals and other governmental agencies. In addition,
the Company has expanded its product  offering to telephone  answering  services
for physicians and disease management  monitoring and other products,  which now
constitute  approximately  20% of the Company's  gross  revenue.  The Company is
continuing  to expand  its  product  offerings  in the  disease  management  and
monitoring  area and is  continuing  to invest in research and  development  for
further product and service  diversification.  The Company would also reduce any
HCSP  overhead  and  re-deploy  assets to other  programs  in the event the HCSP
contract would not continue for any reason.

RESULTS OF OPERATIONS
---------------------
The Company's gross revenue, which consists primarily of monthly rental revenues
("MRR"),  increased  by $292,224  for the three  months  ended March 31, 2003 as
compared  to the same  period  in 2002,  an  increase  of 8%.  Revenue  from the
Company's OnCall telephone  answering service business  increased  approximately
$120,000  primarily due to the execution during the second quarter of 2002 of an
agreement with an entity  involved in cost management and purchasing of services
on behalf of hundreds of healthcare and hospital organizations.  The Company has
also experienced continued growth in its customer base outside the contract with
the City of New York (which experienced a reduction in the number of subscribers
and  revenue  as  compared  to the same  period in 2002)  through  a variety  of
marketing  efforts that have  continued to contribute to increasing  MRR.  These
efforts include expansion into new regions,  competitive conversions,  strategic
partnerships  with  healthcare  provider  systems,  and  additional  entry  into
Medicaid reimbursed marketplaces. This growth resulted in approximately $100,000
of increase.  The  remaining  increase is due to variety of other  smaller items
including revenues generated from the rental and monitoring of the Health Buddy.

Costs related to services increased by $200,471 for the three months ended March
31,  2003 as  compared  to the same  period in 2002,  an increase of 12% . Costs
related to services,  as a percentage of service revenues,  for the three months
ended March 31, 2003 and 2002 were 48% and 46%,  respectively.  The  increase in
costs related to services was due to the Company  adding  personnel  principally
during the second half of 2002 in its telephone  answering  service  division to
handle the current and future growth of that business,  additional payroll costs
associated with the replacement of activators and the Company incurring expenses
related  to the  leasing  of the  Health  Buddy  unit  in  accordance  with  its
Cooperative Licensing,  Development,  Services and Marketing Agreement with HHN.
These items  represented  approximately  $120,000 of the increase.  In addition,
depreciation   for  the  three  months   ended  March  31,  2003   increased  by
approximately  $30,000 as compared  to the same  period in 2002.  As a result of
these increases, the percentage of costs related to services, as a percentage of
service revenues, increased.

Selling, general and administrative expenses increased by $216,883 for the three
months ended March 31, 2003 as compared to the same period in 2002,  an increase
of 12%. Selling,  general, and administrative expenses, as a percentage of total
revenue,  for the three  months  ended March 31, 2003 and 2002 were 51% and 49%,
respectively.  The increase in selling,  general and administrative  expenses is
primarily due the following items:



                                      -16-
<PAGE>

o    Personnel and Related Benefits:
     As part of its plan to  continue  to market and manage  disease  management
     products,  the  Company  increased  the  number of  personnel  in this area
     throughout 2002. This, along with other general  increases in the number of
     personnel as well as  compensation  levels,  increased  payroll and related
     benefits by approximately  $95,000, as compared to the same period in 2002.
     The Company believes the additional  personnel is a necessary  prerequisite
     to facilitate the distribution of its disease management products,  and the
     resulting revenues are expected to be realized in later months.

o    Commission Expense
     Commission  expense increased by approximately  $45,000 in 2003 as compared
     to the same period in 2002, due to two primary factors.  First, in order to
     service its Georgia  Medicaid  subscribers  more  efficiently,  the Company
     retained outside  subcontractors  during the second quarter of 2002 who are
     paid on a commission basis. Secondly, an account that had been a direct pay
     agency  account  during the first quarter of 2002 converted to a commission
     paid account in 2003.

o    Insurance Expense
     Insurance  expense  increased by  approximately  $25,000 as compared to the
     same  period  in  2002.  This is  primarily  due to the  current  insurance
     environment.

o    Computer, Communications and Maintenance
     The Company has incurred increased  maintenance and upkeep costs associated
     with computer and communications networks during the first quarter of 2003,
     which resulted in an increase of  approximately  $25,000 as compared to the
     same period in 2002.

Other increases in selling, general and administrative  expenses,  including put
warrant expense,  trade shows and amortization expense,  including the write-off
of deferred  loan charges,  aggregating  approximately  $60,000,  were offset by
reductions in professional fees and bad debt expense of approximately $45,000.

Interest expense  decreased by $14,535 for the three months ended March 31, 2003
as  compared  to the same  period in 2002.  Interest  expense  decreased  due to
reduced  borrowing  levels  during the first quarter of 2003, as compared to the
comparable period in 2002, as well as a decrease in interest rates.

Other  income  increased by $81,213 for the three months ended March 31, 2003 as
compared to the same period in 2002.  The increase in other income is due to the
inclusion of  approximately  $88,000  relating to the replacement of activators.
Early in 2002, it was found that certain activators  supplied by a vendor may be
subject to battery  failure,  necessitating  the  replacement of all potentially
affected  activators.  The vendor  replaced these  activators and reimbursed the
Company for costs incurred in connection with this  replacement  program.  As of
March 31, 2003,  the  replacement  program was  substantially  completed and the
vendor paid all costs  incurred by the Company in connection  with this program.
Direct costs paid to third parties in connection with the replacements have been
offset  against other income;  internal  costs,  including  labor,  are included
within costs related to services in the consolidated statements of income.



                                      -17-
<PAGE>

The  Company's  income  before  provision  for income taxes for the three months
ended March 31, 2003 was $103,443 as compared to $152,771 for the same period in
2002. The decrease of $49,328  resulted from an increase in the Company's  costs
related to services and selling,  general and administrative  costs offset by an
increase in revenues from services and other income.

RECENT ACCOUNTING PRONOUNCEMENTS:

In April 2002,  SFAS No. 145,  "Rescission of FASB  Statements No. 4, 44 and 64,
Amendment of FASB Statement No. 13, and Technical  Corrections" was issued. This
statement (i) eliminates  extraordinary  accounting treatment for a gain or loss
reported on the  extinguishment of debt, (ii) eliminates  inconsistencies in the
accounting   required  for   sale-leaseback   transactions   and  certain  lease
modifications  with similar  economic  effects,  and (iii) amends other existing
authoritative pronouncements to make technical corrections, clarify meanings, or
describe their applicability under changed conditions.  The Company adopted SFAS
No. 145 effective January 1, 2003. The Company does not expect that the adoption
of this statement  will have a material  impact on its  consolidated  results of
operations or financial position.


In June  2002,  SFAS No.  146,  "Accounting  for Costs  Associated  with Exit or
Disposal  Activities" was issued.  This statement  nullifies  existing  guidance
related  to the  accounting  and  reporting  for costs  associated  with exit or
disposal  activities and requires that the fair value of a liability  associated
with an exit or disposal  activity be recognized when the liability is incurred.
Under  previous  guidance,  certain exit costs were permitted to be accrued upon
management's  commitment  to an exit plan,  which is generally  before an actual
liability has been incurred. The provisions of this statement are required to be
adopted for all exit or disposal  activities  initiated after December 31, 2002.
This statement will not impact any liabilities  recorded prior to adoption.  The
Company  adopted SFAS No. 146  effective  January 1, 2003.  The Company does not
expect that the adoption of this  statement  will have a material  impact on its
consolidated results of operations or financial position.

In December  2002,  the FASB issued  SFAS No. 148,  "Accounting  for Stock Based
Compensation  - Transition and  Disclosure,  an Amendment of FASB Statement 123"
(SFAS 148). SFAS 148 provides new transition alternatives for companies adopting
the fair value method of accounting for stock-based  compensation  prescribed by
SFAS 123. SFAS No. 148 also requires that disclosures of the pro forma effect of
using the fair value method of accounting for stock-based employee  compensation
be displayed more prominently and in tabular format. Additionally,  SFAS No. 148
requires  disclosures of the pro forma effect in interim  financial  statements.
The Company has chosen to continue to account for stock-based compensation using
the  intrinsic  value  method  prescribed  in APB  Opinion  No.  25 and  related
interpretations.  The Company adopted the annual  disclosure  provisions of SFAS
No. 148 in its financial report for the year ended December 31, 2002 and adopted
the interim  disclosure  provisions  for its  financial  reports for the quarter
ended March 31, 2003.



                                      -18-
<PAGE>

CRITICAL ACCOUNTING POLICIES:

In preparing the financial statements, the Company makes estimates,  assumptions
and  judgments  that can have a  significant  impact on our  revenue,  operating
income and net income,  as well as on the reported amounts of certain assets and
liabilities  on the balance  sheet.  The Company  believes  that the  estimates,
assumptions and judgments  involved in the accounting  policies  described below
have the greatest potential impact on its financial statements,  so it considers
these to be its critical accounting  policies.  Estimates in each of these areas
are based on historical experience and a variety of assumptions that the Company
believes are appropriate. Actual results may differ from these estimates.

         RESERVES FOR UNCOLLECTIBLE ACCOUNTS RECEIVABLE
         The Company makes ongoing assumptions relating to the collectibility of
         its accounts receivable.  The accounts receivable amount on the balance
         sheet  includes  a reserve  for  accounts  that  might not be paid.  In
         determining  the  amount of the  reserve,  the  Company  considers  its
         historical  level of credit  losses.  The Company also makes  judgments
         about the  creditworthiness  of significant  customers based on ongoing
         credit evaluations,  and it assesses current economic trends that might
         impact the level of credit losses in the future.  The Company  recorded
         reserves for uncollectible accounts receivable of $555,000 and $540,000
         as of March 31, 2003 and  December 31,  2002,  respectively.  While the
         Company  believes  that the  current  reserves  are  adequate  to cover
         potential  credit  losses,  it cannot  predict  future  changes  in the
         financial  stability of its customers and the Company cannot  guarantee
         that its reserves will continue to be adequate. If actual credit losses
         are  significantly  greater than the reserves  established,  that would
         increase  the  general  and  administrative  expenses  and  reduce  the
         reported  net  income.   Conversely,   if  actual   credit  losses  are
         significantly less than the reserve, this would eventually decrease the
         Company's general and administrative expenses and increase the reported
         net income.

         VALUATION OF LONG-LIVED ASSETS
         The Company reviews long-lived assets for impairment, principally fixed
         assets,  whenever events or changes in circumstances  indicate that the
         carrying  amount  of the  assets  may  not  be  fully  recoverable.  To
         determine   recoverability  of  the  long-lived   assets,  the  Company
         evaluates the probability that future  undiscounted net cash flows will
         be  greater  than the  carrying  amount of its  assets.  Impairment  is
         measured  based on the  difference  between the carrying  amount of the
         assets and their estimated fair value.

         VALUATION OF GOODWILL
         Effective  January 1, 2002, the Company adopted  Statement of Financial
         Accounting  Standards No. 142, "Goodwill and Other Intangible  Assets."
         Under this new standard, goodwill and indefinite life intangible assets
         are no longer  amortized,  but are subject to annual  impairment tests.
         The Company  completed the  transitional  and annual  impairment  tests
         required by SFAS 142 and was not required to recognize an impairment of
         goodwill.  The Company tests goodwill for  impairment  annually or more
         frequently when events or circumstances occur indicating goodwill might
         be  impaired.   This  process  involves  estimating  fair  value  using
         discounted  cash flow  analyses.  Considerable  management  judgment is
         necessary to estimate  discounted  future cash flows.  Assumptions used
         for  these  estimated  cash  flows  were  based  on  a  combination  of


                                      -19-
<PAGE>

         historical results and current internal  forecasts.  The Company cannot
         predict certain events that could  adversely  affect the reported value
         of goodwill,  which totaled  $990,557 at March 31, 2003 and $961,731 at
         December 31, 2002.

         DEFERRED INCOME TAXES
         Deferred  income  taxes  reflect  the  net  tax  effects  of  temporary
         differences  between the carrying amounts of assets and liabilities for
         financial  reporting  purposes  and the  amounts  used for  income  tax
         purposes.  In assessing the  realizability of deferred tax assets,  the
         Company  considers whether it is more likely than not that some portion
         or all of the  deferred  tax assets will not be  realized.  The Company
         considers the scheduled reversal of deferred tax liabilities, projected
         future  taxable  income,  and tax  planning  strategies  in making this
         assessment and records a valuation allowance to reduce the deferred tax
         assets to the amount that is expected to be realized in future periods.

ITEM 3.    CONTROLS AND PROCEDURES.

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Within 90 days prior to the date of this  report,  the  Company  carried  out an
evaluation,  under the supervision and with the  participation  of the Company's
management,  including the Company's President and Chief Executive Officer along
with the Company's  Chief  Financial  Officer,  as to the  effectiveness  of the
design and operation of the Company's  "disclosure  controls and procedures" (as
defined  in  Exchange  Act  Rules  13a-14(c)  and  15d-14(c)).   Based  on  this
evaluation,  the  President  and Chief  Executive  Officer  along with the Chief
Financial  Officer have  concluded  that the Company's  disclosure  controls and
procedures were effective.

CHANGES IN INTERNAL CONTROLS

There were no significant changes in the Company's internal controls,  or to the
Company's  knowledge,  in other  factors  that  could  significantly  affect the
Company's disclosure controls and procedures subsequent to May 8, 2003.

PART II - OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS.
           -----------------
The Company is aware of various  threatened or pending litigation claims against
the Company  relating to its products and arising in the ordinary  course of its
business.  The Company has given its insurance carrier notice of such claims and
it believes there is sufficient  insurance coverage to cover any such claims. In
any event, the Company believes the disposition of these matters will not have a
material adverse effect on the financial condition of the Company.

On March 2, 2001  American  Medical  Alert  Corp.  was served with a Summons and
Complaint by a former employee seeking to recover damages for discrimination and
harassment in connection  with her  employment  and the  associated  termination
thereof.  The action is  pending  in the



                                      -20-
<PAGE>

Supreme  Court of Queens  County.  The  plaintiff  seeks to  recover  the sum of
$750,000 for  compensatory  damages and $750,000 for punitive  damages.  At this
stage of the  proceedings,  it is not  possible  to predict  the outcome of this
litigation;  however,  management  believes  that the  Company  has  meritorious
defenses to the  complaint.  The  Company is  currently  involved in  settlement
negotiations  with  respect to this matter.  At the present  time the  insurance
company has declined coverage.

ITEM 6.    EXHIBIT AND REPORTS ON FORM 8-K.

(a)   Exhibits:

No.   Description
---   -----------

99.1  Certification of CEO Pursuant to Section 906 of the
      Sarbanes Oxley Act of 2002
99.2  Certification of CFO Pursuant to Section 906 of the
      Sarbanes Oxley Act of 2002

(b)   Reports on Form 8-K:

On March 31, 2003,  the Company  filed a Current  Report on Form 8-K relating to
Item 12, Results of Operations and Financial Conditions,  reporting the issuance
of a press release  announcing the Company's results for the year ended December
31, 2002.



                                      -21-
<PAGE>


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.

                                        AMERICAN MEDICAL ALERT CORP.


Dated:  May 15, 2003                    By: /s/ Howard M. Siegel
                                           -------------------------------------
                                           Howard M. Siegel
                                           President and Chief Executive Officer


                                        By: /s/ Richard Rallo
                                           -------------------------------------
                                           Richard Rallo
                                           Controller (chief financial officer)




                                      -22-
<PAGE>


                 CERTIFICATION FOR QUARTERLY REPORT ON FORM 10-QSB
                 -------------------------------------------------

I, Howard M. Siegel, certify that:

1.   I have reviewed this  quarterly  report on Form 10-QSB of American  Medical
     Alert Corp.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in this  quarterly  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     quarterly report;

4.   The  registrant's  other  certifying  officers  and I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a)   Designed such  disclosure  controls and  procedures to ensure that material
     information   relating  to  the  registrant,   including  its  consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

b)   Evaluated the  effectiveness  of the registrant's  disclosure  controls and
     procedures  as of a date  within 90 days prior to the  filing  date of this
     quarterly report (the "Evaluation Date"); and

c)   Presented in this quarterly report our conclusions  about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

5.   The registrant's other certifying  officers and I have disclosed,  based on
     our most recent  evaluation,  to the  registrant's  auditors  and the audit
     committee of  registrant's  board of directors (or persons  performing  the
     equivalent function):

a)   All  significant  deficiencies  in the  design  or  operation  of  internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     registrant's auditors any material weaknesses in internal controls; and

b)   Any fraud,  whether or not  material,  that  involves  management  or other
     employees  who  have  a  significant  role  in  the  registrant's  internal
     controls; and

6.   The  registrant's  other  certifying  officers and I have indicated in this
     quarterly report whether or not there were significant  changes in internal
     controls  or in other  factors  that could  significantly  affect  internal
     controls  subsequent to the date of our most recent  evaluation,  including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

Date: May 15 , 2003                     /s/ Howard M. Siegel
                                        ---------------------------------------
                                        Howard M. Siegel
                                        President and Chief Executive Officer



                                      -23-
<PAGE>

                 CERTIFICATION FOR QUARTERLY REPORT ON FORM 10-QSB
                 -------------------------------------------------

I, Richard Rallo, certify that:

1.   I have reviewed this  quarterly  report on Form 10-QSB of American  Medical
     Alert Corp.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in this  quarterly  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     quarterly report;

4.   The  registrant's  other  certifying  officers  and I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a)   Designed such  disclosure  controls and  procedures to ensure that material
     information   relating  to  the  registrant,   including  its  consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

b)   Evaluated the  effectiveness  of the registrant's  disclosure  controls and
     procedures  as of a date  within 90 days prior to the  filing  date of this
     quarterly report (the "Evaluation Date"); and

c)   Presented in this quarterly report our conclusions  about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

5.   The registrant's other certifying  officers and I have disclosed,  based on
     our most recent  evaluation,  to the  registrant's  auditors  and the audit
     committee of  registrant's  board of directors (or persons  performing  the
     equivalent function):

a)   All  significant  deficiencies  in the  design  or  operation  of  internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     registrant's auditors any material weaknesses in internal controls; and

b)   Any fraud,  whether or not  material,  that  involves  management  or other
     employees  who  have  a  significant  role  in  the  registrant's  internal
     controls; and

6.   The  registrant's  other  certifying  officers and I have indicated in this
     quarterly report whether or not there were significant  changes in internal
     controls  or in other  factors  that could  significantly  affect  internal
     controls  subsequent to the date of our most recent  evaluation,  including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

Date: May 15 , 2003                     /s/ Richard Rallo
                                        ----------------------------------------
                                        Richard Rallo
                                        Controller (Chief Financial Officer)





                                      -24-